KRAB Zinc-Finger Protein ZNF205 Promotes Hepatocellular Carcinoma via p53 Pathway Repression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The tumor suppressor p53 is frequently dysregulated in cancer, but the mechanisms of its impairment are not fully understood.
• KRAB domain-containing zinc finger proteins (KZFPs) have been identified as key regulators of p53 in tumorigenesis.
• Specific KZFPs and their roles in cancer require further investigation.

Purpose of the Study:

• To identify and characterize novel regulators of p53 in hepatocellular carcinoma (HCC).
• To elucidate the specific mechanisms by which ZNF205 affects p53 activity and HCC progression.
• To evaluate ZNF205 as a potential therapeutic target for restoring p53 function in HCC.

Main Methods:

• Pan-cancer analysis to assess ZNF205 as a prognostic factor in HCC.
• Co-immunoprecipitation assays to investigate ZNF205-p53 interaction.
• Functional assays (in vitro and in vivo) to determine the effect of ZNF205 modulation on HCC cell malignancy.
• Assessment of p53 transcriptional activity and binding to target genes.

Main Results:

• ZNF205 was identified as an unfavorable prognostic factor in p53 wild-type HCC patients.
• ZNF205 directly interacts with p53, inhibiting its transcriptional activity by blocking p53 binding to target genes.
• Overexpression of ZNF205 enhanced HCC malignancy, while knockdown suppressed it, in a p53-dependent manner.
• ZNF205 was confirmed to play a pro-tumorigenic role in HCC.

Conclusions:

• ZNF205 is a novel oncogenic regulator in HCC that inactivates the tumor suppressor p53.
• This study reveals a new mechanism of p53 dysregulation in HCC mediated by KZFPs.
• ZNF205 represents a promising therapeutic target for restoring p53 function and treating HCC.